New Search


Developing Overdose Prevention Programs for Washington State

Principal Investigator:
Caleb Banta-Green, PhD, MPH, MSW
Research Scientist
Alcohol and Drug Abuse Institute
calebbg@u.washington.edu
http://bit.ly/adaistaff_bantagreen

Date: May 1, 2012 to August 31, 2013
Sponsor: Washington State Office of the Attorney General
Categories: Overdose Prevention

Other Investigators: Mary Catlin, MPH, BSN, Research Coordinator


Description: This proposal aims to broaden awareness of overdose and provide information about how to recognize and intervene in opiate overdoses to save lives. We will develop, implement and evaluate the acceptability and feasibility of new trainings utilizing three different modes: in-person, interactive webinar, and web based. Bus advertising will be utilized in two counties to educate the general public and direct them to online training and educational materials.

Related Web Sites:
StopOverdose.org


Evaluation of a Public Health Law to Support Intervening in Drug Overdose

Principal Investigator:
Caleb Banta-Green, PhD, MPH, MSW
Research Scientist
Alcohol and Drug Abuse Institute
calebbg@u.washington.edu
http://bit.ly/adaistaff_bantagreen

Date: November 15, 2010 to May 14, 2012
Sponsor: Robert Wood Johnson Foundation (RWJF # 68396)
Categories: Overdose Prevention | Social Policy

Other Investigators: Patricia Kuszler, MD, JD (Co-PI); Phillip Coffin MD MIA (Co-Investigator); Jennie Schoeppe, Research Coordinator


Description: This study will examine the legal intent, implementation and outcomes of a new Washington state law to support intervening in drug overdoses. The law includes a "911 Good Samaritan" component that provides legal immunity from drug possession charges for people who overdose or seek aid for another person’s overdose. It also allows the prescribing of an opioid antidote medicine (naloxone) to drug users and their partners. Evaluation will be conducted on the development of the legislation and the impact of the law on Seattle area heroin users, bystanders, and police during overdoses as well as the impacts on community health outcomes.

Related Web Sites:
Project on RWJF website
StopOverdose.org website

Evaluation of the Feasibility and Potential Impacts for Seattle Police Department Officers to Carry and Administer Naloxone for Opioid Overdose Reversal

Principal Investigator:
Caleb Banta-Green, PhD, MPH, MSW
Senior Research Scientist
Alcohol and Drug Abuse Institute
calebbg@u.washington.edu
http://bit.ly/adaistaff_bantagreen

Date: May 1, 2016 to April 30, 2017
Sponsor: Seattle Police Department
Categories: Overdose Prevention | Implementation Research


Description: This goals of this project are to 1) evaluate the feasibility and potential impacts of a Seattle Police Department Pilot Program, in cooperation with the Seattle Fire Department (SFD), to carry and administer naloxone for opioid overdose reversal; and 2) evaluate whether training police officers to recognize and respond to opioid overdoses impacts the health of those who have an opioid overdose, and/or impacts the officer’s perceptions of their role as a police officer or their perceptions of opioid addiction and opioid users.

Prescription Drug Overdose Prevention for States

Principal Investigator:
Caleb Banta-Green, PhD, MPH, MSW
Senior Research Scientist
Alcohol and Drug Abuse Institute
calebbg@u.washington.edu
http://bit.ly/adaistaff_bantagreen

Date: August 1, 2016 to August 31, 2017
Sponsor: Washington State Department of Health through a grant from the CDC
Categories: Epidemiology and Drug Abuse Trends | Prescription Drug Abuse | Overdose Prevention

Other Investigators: Ryan Hansen, PharmD, PhD, Lauren Whiteside, MD


Description: In response to Centers for Disease Control and Prevention (CDC) Priority Strategy 1 the UW will support and evaluate DOH efforts to expand and improve proactive Prescription Monitoring Program (PMP) reporting. This will include contributing to the design of new reports based on the research literature as well as analyses of existing WA State PMP data conducted by the UW. The impact of new proactive reports will be examined via longitudinal analyses of PMP data. The UW will be involved in guiding analyses to be conducted by DOH staff as well as the interpretation of statistical analyses and the writing of relevant evaluation findings. Drs. Banta- Green and Hansen will support this task.

In support of Priority Strategy 2, and a DOH nurse consultant who will be providing community and prescriber technical assistance to prevent overdoses, Dr. Banta-Green will work closely with DOH and the nurse consultant to inform and coordinate the activities with Dr. Banta-Green’s Center for Opioid Safety Education at the UW.

As part of Priority Strategy 3, Drs. Banta-Green, Whiteside and Hansen, will help design and oversee an evaluation of the connection between the PMP and the Emergency Department Information Exchange. Analyses at the ED, prescriber and patient levels will be conducted.

As another component in response to Priority Strategy 3, Drs. Banta-Green and Hansen will be involved in examining the impact of WA State’s Pain Rules and other longitudinal analyses of policy and practice changes.

As part of Priority Strategy 4, Rapid Response Projects, Dr. Banta-Green will lead the effort to utilize electronic Emergency Medical Systems (EMS), aka ambulance, electronic data to enhance the capacity to use these systems to conduct surveillance for opioid overdose occurrence and document community based interventions. This will include working with EMS systems across WA State, and their software vendors, to determine the capacity of existing systems and data fields to capture information for opioid overdose surveillance as well as the technical capacity to gather new information on bystander and law enforcement administered aid to overdose victims. In collaboration with DOH and CDC, a multi-year plan to improve data collection via data system enhancement and paramedic training will be developed and implemented. The utility of these data to support opioid overdose surveillance and document the occurrence and impact of community based interventions will be examined.


A Trial to Prevent Opioid Overdose: E.D. Based Intervention & Take-Home Naloxone.

Principal Investigator:
Caleb Banta-Green, PhD, MPH, MSW
Senior Research Scientist
Alcohol and Drug Abuse Institute
calebbg@u.washington.edu
http://bit.ly/adaistaff_bantagreen

Date: May 15, 2012 to April 30, 2017
Sponsor: National Institute on Drug Abuse (1R01DA030351-01A1)
Categories: Overdose Prevention | Prescription Drug Abuse

Other Investigators: Anthony Floyd, PhD


Description: This prospective, randomized controlled study will test an emergency department based intervention with 500 heroin and 500 pharmaceutical opioid users at high risk for overdose. The intervention includes a brief behavioral change counseling session, overdose education and take-home naloxone. Outcomes will include overdose and HIV risk behaviors, overdose occurrence, and health services utilization and costs.

Related Web Sites:
StopOverdose.org
NIH RePORTER record

Washington State Innovation Initiative: Medication Assisted Treatment Upon Release from Prison

Principal Investigator:
Caleb Banta-Green, PhD, MPH, MSW
Senior Research Scientist
Alcohol and Drug Abuse Institute
calebbg@u.washington.edu
http://bit.ly/adaistaff_bantagreen

Date: August 1, 2016 to July 31, 2018
Sponsor: Laura and John Arnold Foundation
Categories: Overdose Prevention | Implementation Research

Other Investigators: Theresa Hoeft, PhD, Judith Tsui, PhD, Jeanne Sears, MD, MPH


Description: The goal of this study is to develop, implement, and assess the feasibility of procedures to provide effective services for offenders with OUD releasing from WA DOC prisons, with the aim to facilitate linkage to ongoing MAT in the community following release from custody beginning with an initial intervention aimed to educate inmates so they can make informed decisions regarding medication options.

Washington State Project to Prevent Prescription Drug / Opioid Overdose

Principal Investigator:
Caleb Banta-Green, PhD, MPH, MSW
Senior Research Scientist, Alcohol and Drug Abuse Institute
Affiliate Associate Professor, School of Public Health
calebbg@u.washington.edu
http://bit.ly/adaistaff_bantagreen

Date: September 1, 2016 to August 31, 2021
Sponsor: Washington State Division of Behavioral Health & Recovery (SP-16-005; (CFDA) NO.: 93.243)
Categories: Overdose Prevention | Prescription Drug Abuse

Other Investigators: Susan Kingston, Program Operations Specialist


Description: The Washington State Project to Prevent Prescription Drug/Opioid Overdose is a statewide network of organizations mobilizing communities, providing overdose response training, and distributing naloxone through syringe exchange programs in four high need areas. Activities engage professional and lay first responders, pharmacies, local and regional stakeholders and health care providers to reduce overdose risk and deaths among people who use heroin and prescription opioids.

The Washington State Project to Prevent Prescription Drug/Opioid Overdose (WA-PDO) will be a collaborative five-year project between the Washington Department of Social and Health Services’ (DSHS) Division of Behavioral Health and Recovery (DBHR) and the University of Washington’s Alcohol and Drug Abuse Institute (ADAI) with the purpose of preventing opioid overdose and deaths from opioid overdose, and building local infrastructure to plan, implement, evaluate, and fund overdose prevention efforts in the long-term. WA-PDO will develop a network of opioid overdose experts and interventions to efficiently extend core overdose prevention expertise and centralized resources at ADAI’s Center for Opioid Safety Education program (COSE) to four diverse, high-need areas (HNA) across the state. With COSE as the central hub and the four regional nodes coordinating WA-PDO overdose prevention activities, WA-PDO will reach adults who use prescription opioids/heroin and professionals and community members who may be the first responders at an overdose. Core interventions include stakeholder engagement, overdose prevention/response training, and naloxone distribution. Objectives include:1) develop overdose prevention strategic plans in four HNAs; 2) equip 2,400 police, fire, and emergency medical services personnel (PFEMS) with overdose response training/naloxone; 3) equip 13,200 lay responders (LR) with overdose response training/naloxone 4) increase naloxone dispensed by pharmacists by 20% each year; 5) educate 1,400 health care providers on opioid guidelines, patient overdose education, and naloxone and opioid use disorders; 6) develop new models of substance use treatment linkage and care coordination in four HNAs; 7) facilitate coordination in four HNAs among local andregional stakeholders and with state agencies; 8) build and harmonize data infrastructures to inform resource allocation, maintain overdose surveillance, and measure outcomes; and 9) create knowledge translation infrastructure to disseminate emerging data, best practices, training, and technical assistance. Over the five-year project, our activities will reach 2,400 PFEMS responders, 13,200 lay responders, 1,400 health care providers, 120 pharmacies, and 160 community organizations across four priority regions.

Related Web Sites:
http://stopoverdose.org/cose/


Powered by DB/Text WebPublisher, from Inmagic WebPublisher PRO